Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Oral Mucosal Injury Caused by Targeted Cancer Therapies.

Carrozzo M, Eriksen JG, Bensadoun RJ, Boers-Doets CB, Lalla RV, Peterson DE.

J Natl Cancer Inst Monogr. 2019 Aug 1;2019(53). pii: lgz012. doi: 10.1093/jncimonographs/lgz012.

PMID:
31425602
2.

Oral Mucositis Due to High-Dose Chemotherapy and/or Head and Neck Radiation Therapy.

Lalla RV, Brennan MT, Gordon SM, Sonis ST, Rosenthal DI, Keefe DM.

J Natl Cancer Inst Monogr. 2019 Aug 1;2019(53). pii: lgz011. doi: 10.1093/jncimonographs/lgz011.

PMID:
31425601
3.

Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines.

Bowen JM, Gibson RJ, Coller JK, Blijlevens N, Bossi P, Al-Dasooqi N, Bateman EH, Chiang K, de Mooij C, Mayo B, Stringer AM, Tissing W, Wardill HR, van Sebille YZA, Ranna V, Vaddi A, Keefe DM, Lalla RV, Cheng KKF, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2019 Oct;27(10):4011-4022. doi: 10.1007/s00520-019-04892-0. Epub 2019 Jul 8.

PMID:
31286233
4.

Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines.

Hong CHL, Gueiros LA, Fulton JS, Cheng KKF, Kandwal A, Galiti D, Fall-Dickson JM, Johansen J, Ameringer S, Kataoka T, Weikel D, Eilers J, Ranna V, Vaddi A, Lalla RV, Bossi P, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2019 Oct;27(10):3949-3967. doi: 10.1007/s00520-019-04848-4. Epub 2019 Jul 8.

PMID:
31286232
5.

The pathogenesis of mucositis: updated perspectives and emerging targets.

Bowen J, Al-Dasooqi N, Bossi P, Wardill H, Van Sebille Y, Al-Azri A, Bateman E, Correa ME, Raber-Durlacher J, Kandwal A, Mayo B, Nair RG, Stringer A, Ten Bohmer K, Thorpe D, Lalla RV, Sonis S, Cheng K, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2019 Oct;27(10):4023-4033. doi: 10.1007/s00520-019-04893-z. Epub 2019 Jul 8.

PMID:
31286231
6.

Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines.

Ariyawardana A, Cheng KKF, Kandwal A, Tilly V, Al-Azri AR, Galiti D, Chiang K, Vaddi A, Ranna V, Nicolatou-Galitis O, Lalla RV, Bossi P, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2019 Oct;27(10):3985-3995. doi: 10.1007/s00520-019-04888-w. Epub 2019 Jul 8.

PMID:
31286230
7.

Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements.

Yarom N, Hovan A, Bossi P, Ariyawardana A, Jensen SB, Gobbo M, Saca-Hazboun H, Kandwal A, Majorana A, Ottaviani G, Pentenero M, Nasr NM, Rouleau T, Lucas AS, Treister NS, Zur E, Ranna V, Vaddi A, Cheng KKF, Barasch A, Lalla RV, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer / International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2019 Oct;27(10):3997-4010. doi: 10.1007/s00520-019-04887-x. Epub 2019 Jul 8.

PMID:
31286229
8.

Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines.

Zadik Y, Arany PR, Fregnani ER, Bossi P, Antunes HS, Bensadoun RJ, Gueiros LA, Majorana A, Nair RG, Ranna V, Tissing WJE, Vaddi A, Lubart R, Migliorati CA, Lalla RV, Cheng KKF, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2019 Oct;27(10):3969-3983. doi: 10.1007/s00520-019-04890-2. Epub 2019 Jul 8.

PMID:
31286228
9.

Development of the MASCC/ISOO clinical practice guidelines for mucositis: an overview of the methods.

Ranna V, Cheng KKF, Castillo DA, Porcello L, Vaddi A, Lalla RV, Bossi P, Elad S; Mucositis Study group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2019 Oct;27(10):3933-3948. doi: 10.1007/s00520-019-04891-1. Epub 2019 Jul 8.

PMID:
31286227
10.

Evaluation of an Experiential and Self-Learning Approach to Teaching Evidence-Based Decision Making to Dental Students.

Lalla RV, Li EY, Huedo-Medina TB, MacNeil RLM.

J Dent Educ. 2019 Oct;83(10):1125-1133. doi: 10.21815/JDE.019.125. Epub 2019 Jul 8.

PMID:
31285368
11.

Recurrent oral ulceration: Etiology, classification, management, and diagnostic algorithm.

Bilodeau EA, Lalla RV.

Periodontol 2000. 2019 Jun;80(1):49-60. doi: 10.1111/prd.12262. Review.

PMID:
31090148
12.

Caries-associated oral microbiome in head and neck cancer radiation patients: a longitudinal study.

Mougeot JC, Stevens CB, Almon KG, Paster BJ, Lalla RV, Brennan MT, Mougeot FB.

J Oral Microbiol. 2019 Mar 8;11(1):1586421. doi: 10.1080/20002297.2019.1586421. eCollection 2019.

13.

Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.

Nicolatou-Galitis O, Kouri M, Papadopoulou E, Vardas E, Galiti D, Epstein JB, Elad S, Campisi G, Tsoukalas N, Bektas-Kayhan K, Tan W, Body JJ, Migliorati C, Lalla RV; MASCC Bone Study Group.

Support Care Cancer. 2019 Feb;27(2):383-394. doi: 10.1007/s00520-018-4501-x. Epub 2018 Oct 23.

PMID:
30353228
14.

Afatinib Therapy: Practical Management of Adverse Events With an Oral Agent for Non-Small Cell Lung Cancer Treatment.

Edwards RL, Andan C, Lalla RV, Lacouture ME, O'Brien D, Sequist LV.

Clin J Oncol Nurs. 2018 Oct 1;22(5):542-548. doi: 10.1188/18.CJON.542-548. Review.

PMID:
30239509
15.

Transient bacteremia induced by dental cleaning is not associated with infection of central venous catheters in patients with cancer.

Usmani S, Choquette L, Bona R, Feinn R, Shahid Z, Lalla RV.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Apr;125(4):286-294. doi: 10.1016/j.oooo.2017.12.022. Epub 2018 Jan 11.

16.

Anticoagulants are dental friendly.

Wahl MJ, Miller CS, Rhodus NL, Kämmerer P, Dinkova A, Lalla RV, Bajkin BV.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Feb;125(2):103-106. doi: 10.1016/j.oooo.2017.11.006. Epub 2017 Nov 16. No abstract available.

PMID:
29249522
17.

Dental disease before radiotherapy in patients with head and neck cancer: Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients.

Brennan MT, Treister NS, Sollecito TP, Schmidt BL, Patton LL, Mohammadi K, Long Simpson L, Voelker H, Hodges JS, Lalla RV.

J Am Dent Assoc. 2017 Dec;148(12):868-877. doi: 10.1016/j.adaj.2017.09.011. Erratum in: J Am Dent Assoc. 2018 Feb;149(2):89.

18.

Dental Treatment Planning for the Patient with Oral Cancer.

Levi LE, Lalla RV.

Dent Clin North Am. 2018 Jan;62(1):121-130. doi: 10.1016/j.cden.2017.08.009. Epub 2017 Oct 7. Review.

PMID:
29126489
19.

Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis.

Sroussi HY, Epstein JB, Bensadoun RJ, Saunders DP, Lalla RV, Migliorati CA, Heaivilin N, Zumsteg ZS.

Cancer Med. 2017 Dec;6(12):2918-2931. doi: 10.1002/cam4.1221. Epub 2017 Oct 25. Review.

20.

Oral complications at 6 months after radiation therapy for head and neck cancer.

Lalla RV, Treister N, Sollecito T, Schmidt B, Patton LL, Mohammadi K, Hodges JS, Brennan MT; OraRad Study Group.

Oral Dis. 2017 Nov;23(8):1134-1143. doi: 10.1111/odi.12710. Epub 2017 Aug 3.

21.

Clinical registry of dental outcomes in head and neck cancer patients (OraRad): rationale, methods, and recruitment considerations.

Lalla RV, Long-Simpson L, Hodges JS, Treister N, Sollecito T, Schmidt B, Patton LL, Brennan MT; OraRad Study Group.

BMC Oral Health. 2017 Feb 27;17(1):59. doi: 10.1186/s12903-017-0344-y.

22.

Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements.

De Sanctis V, Bossi P, Sanguineti G, Trippa F, Ferrari D, Bacigalupo A, Ripamonti CI, Buglione M, Pergolizzi S, Langendjik JA, Murphy B, Raber-Durlacher J, Russi EG, Lalla RV.

Crit Rev Oncol Hematol. 2016 Apr;100:147-66. doi: 10.1016/j.critrevonc.2016.01.010. Epub 2016 Feb 1. Review.

PMID:
26947812
23.

Pilot study on the efficacy of combined intraoral and extraoral low-level laser therapy for prevention of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation.

Soto M, Lalla RV, Gouveia RV, Zecchin VG, Seber A, Lopes NN.

Photomed Laser Surg. 2015 Nov;33(11):540-6. doi: 10.1089/pho.2015.3954. Epub 2015 Oct 26.

PMID:
26501372
24.

Ultrasensitive microfluidic array for serum pro-inflammatory cytokines and C-reactive protein to assess oral mucositis risk in cancer patients.

Krause CE, Otieno BA, Bishop GW, Phadke G, Choquette L, Lalla RV, Peterson DE, Rusling JF.

Anal Bioanal Chem. 2015 Sep;407(23):7239-43. doi: 10.1007/s00216-015-8873-1. Epub 2015 Jul 5.

25.

Dental surgery in anticoagulated patients--stop the interruption.

Wahl MJ, Pinto A, Kilham J, Lalla RV.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Feb;119(2):136-57. doi: 10.1016/j.oooo.2014.10.011. Epub 2014 Nov 13. Review.

PMID:
25577414
26.

Erratum to: Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients.

Saunders DP, Epstein JB, Elad S, Allemano J, Bossi P, van de Wetering MD, Rao NG, Potting C, Cheng KK, Freidank A, Brennan MT, Bowen J, Dennis K, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2015 Feb;23(2):601-2. doi: 10.1007/s00520-014-2542-3. No abstract available.

PMID:
25475737
27.

Alleviating mucositis: are we on track for a novel therapeutic?

Lalla RV.

Expert Rev Gastroenterol Hepatol. 2015 Feb;9(2):127-8. doi: 10.1586/17474124.2015.965146. Epub 2014 Oct 1.

PMID:
25270956
28.

Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer.

Lalla RV, Choquette LE, Curley KF, Dowsett RJ, Feinn RS, Hegde UP, Pilbeam CC, Salner AL, Sonis ST, Peterson DE.

Oral Oncol. 2014 Nov;50(11):1098-103. doi: 10.1016/j.oraloncology.2014.08.001. Epub 2014 Aug 21.

29.

Antifungal medications or disinfectants for denture stomatitis.

Lalla RV, Dongari-Bagtzoglou A.

Evid Based Dent. 2014 Jun;15(2):61-2. doi: 10.1038/sj.ebd.6401032.

PMID:
24971864
30.

Chemotherapy or radiation-induced oral mucositis.

Lalla RV, Saunders DP, Peterson DE.

Dent Clin North Am. 2014 Apr;58(2):341-9. doi: 10.1016/j.cden.2013.12.005. Review.

PMID:
24655526
31.

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S; Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO).

Cancer. 2014 May 15;120(10):1453-61. doi: 10.1002/cncr.28592. Epub 2014 Feb 25. Review. Erratum in: Cancer. 2015 Apr 15;121(8):1339.

32.

Mammalian target of rapamycin inhibitor-associated stomatitis.

Boers-Doets CB, Raber-Durlacher JE, Treister NS, Epstein JB, Arends AB, Wiersma DR, Lalla RV, Logan RM, van Erp NP, Gelderblom H.

Future Oncol. 2013 Dec;9(12):1883-92. doi: 10.2217/fon.13.141. Review.

33.

Oral mucosal injury in oncology patients: perspectives on maturation of a field.

Peterson DE, Srivastava R, Lalla RV.

Oral Dis. 2015 Mar;21(2):133-41. doi: 10.1111/odi.12167. Epub 2013 Oct 16. Review.

PMID:
24131518
34.

Interruption of warfarin anticoagulation for dental surgery.

Wahl MJ, Pinto A, Lalla RV.

Chest. 2013 Oct;144(4):1424. doi: 10.1378/chest.13-1366. No abstract available.

PMID:
24081367
35.

Systematic review of basic oral care for the management of oral mucositis in cancer patients.

McGuire DB, Fulton JS, Park J, Brown CG, Correa ME, Eilers J, Elad S, Gibson F, Oberle-Edwards LK, Bowen J, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Nov;21(11):3165-77. doi: 10.1007/s00520-013-1942-0. Epub 2013 Sep 10. Review.

PMID:
24018908
36.

The MASCC/ISOO mucositis guidelines: dissemination and clinical impact.

Lalla RV, Ashbury FD.

Support Care Cancer. 2013 Nov;21(11):3161-3. doi: 10.1007/s00520-013-1924-2. Epub 2013 Aug 14. No abstract available.

PMID:
23942597
37.

Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients.

Jensen SB, Jarvis V, Zadik Y, Barasch A, Ariyawardana A, Hovan A, Yarom N, Lalla RV, Bowen J, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Nov;21(11):3223-32. doi: 10.1007/s00520-013-1884-6. Epub 2013 Jul 31. Review.

PMID:
23900593
38.

Emerging evidence on the pathobiology of mucositis.

Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Nov;21(11):3233-41. doi: 10.1007/s00520-013-1900-x. Epub 2013 Jul 11. Review.

PMID:
23842598
39.

Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients.

Saunders DP, Epstein JB, Elad S, Allemano J, Bossi P, van de Wetering MD, Rao NG, Potting C, Cheng KK, Freidank A, Brennan MT, Bowen J, Dennis K, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Nov;21(11):3191-207. doi: 10.1007/s00520-013-1871-y. Epub 2013 Jul 6. Review. Erratum in: Support Care Cancer. 2015 Feb;23(2):601-2. Dosage error in article text.

PMID:
23832272
40.

Systematic review of natural agents for the management of oral mucositis in cancer patients.

Yarom N, Ariyawardana A, Hovan A, Barasch A, Jarvis V, Jensen SB, Zadik Y, Elad S, Bowen J, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Nov;21(11):3209-21. doi: 10.1007/s00520-013-1869-5. Epub 2013 Jun 14. Review.

PMID:
23764678
41.

Oral candidiasis: pathogenesis, clinical presentation, diagnosis and treatment strategies.

Lalla RV, Patton LL, Dongari-Bagtzoglou A.

J Calif Dent Assoc. 2013 Apr;41(4):263-8. Review.

PMID:
23705242
42.

Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients.

Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias VE, Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Nov;21(11):3179-89. doi: 10.1007/s00520-013-1847-y. Epub 2013 May 24. Review.

PMID:
23702538
43.

Emerging evidence on the pathobiology of mucositis.

Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV; Mucositis Study Group of Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Jul;21(7):2075-83. doi: 10.1007/s00520-013-1810-y. Epub 2013 Apr 21. Review.

PMID:
23604521
44.

Retrospective study of microorganisms associated with vascular access infections in hemodialysis patients.

D'Amato-Palumbo S, Kaplan AA, Feinn RS, Lalla RV.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jan;115(1):56-61. doi: 10.1016/j.oooo.2012.08.445.

45.

The MASCC/ISOO Mucositis Guidelines Update: introduction to the first set of articles.

Lalla RV.

Support Care Cancer. 2013 Jan;21(1):301-2. doi: 10.1007/s00520-012-1660-z. Epub 2012 Nov 17. No abstract available.

PMID:
23161340
46.

Systematic review of agents for the management of gastrointestinal mucositis in cancer patients.

Gibson RJ, Keefe DM, Lalla RV, Bateman E, Blijlevens N, Fijlstra M, King EE, Stringer AM, van der Velden WJ, Yazbeck R, Elad S, Bowen JM; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Jan;21(1):313-26. doi: 10.1007/s00520-012-1644-z. Epub 2012 Nov 10. Review.

PMID:
23142924
47.

Validation of anamnestic diagnostic criteria for recurrent aphthous stomatitis.

Baccaglini L, Theriaque DW, Shuster JJ, Serrano G, Lalla RV.

J Oral Pathol Med. 2013 Apr;42(4):290-4. doi: 10.1111/jop.12015. Epub 2012 Oct 27.

48.

Development of the MASCC/ISOO Clinical Practice Guidelines for Mucositis: considerations underlying the process.

Elad S, Bowen J, Zadik Y, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Jan;21(1):309-12. doi: 10.1007/s00520-012-1593-6. Epub 2012 Oct 13.

PMID:
23064884
49.

Systematic review of amifostine for the management of oral mucositis in cancer patients.

Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias VE, Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Jan;21(1):357-64. doi: 10.1007/s00520-012-1613-6. Epub 2012 Oct 3. Review.

PMID:
23052919
50.

Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients.

Migliorati C, Hewson I, Lalla RV, Antunes HS, Estilo CL, Hodgson B, Lopes NN, Schubert MM, Bowen J, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Jan;21(1):333-41. doi: 10.1007/s00520-012-1605-6. Epub 2012 Sep 22. Review.

PMID:
23001179

Supplemental Content

Loading ...
Support Center